Uploaded January 2022 | Updated November 2026, 5 days ago
Dr. Greg Fahy gives an update on the TRIIM-X clinical trial at EARD 2021.
The TRIIM-X clinical trial aims to understand how to create a personalized thymus regeneration regimen. By regenerating the thymus, the researchers hope to be able to prevent or reverse certain aspects of immune system aging.
FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io
DESCRIPTION
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Dr. Fahy holds a Bachelor of Science degree in Biology from the University of California at Irvine and a Ph.D. from the Medical College of Georgia in Augusta. Dr. Fahy used to be the Head of the Tissue Cryopreservation Section of the Transfusion and Cryopreservation Research Program for the U.S. Naval Medical Research Institute in Bethesda, Maryland, where he developed the original concept of ice blocking agents.
Dr. Fahy is the Chief Scientific Officer and co-founder of Intervene Immune, a biotech company researching rejuvenation of the immune system, particularly the thymus. He designed and led the TRIIM trial, published the first report of thymus regeneration in a normal human, and granted patents on methods for and applications of human thymus regeneration. Before his time at 21st Century Medicine, where he is the Executive Director and Chief Scientific Officer, Dr. Fahy pioneered the practical use of cryopreservation by vitrification and invented a computer system to apply this technology to organs at the American Red Cross.
Dr. Fahy is also a biogerontologist and is the originator and Editor-in-Chief of The Future of Aging: Pathways to Human Life Extension, a multi-authored book about the future of biogerontology.
For 16 years, Dr. Fahy worked as a Director of the American Aging Association and for 6 years as the editor of AGE News, the organization’s newsletter. He currently serves on the editorial boards of Rejuvenation Research and the Open Geriatric Medicine Journal.
The annual Ending Age-Related Diseases (EARD) conference by Lifespan.io brings together longevity thought leaders together to exchange research reports, inspire and get inspired with new ideas, find collaborators, supporters, and mentors.
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero:
lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io
#EARD2021 #Longevity #thymus #thymusregeneration
Dr. Greg Fahy gives an update on the TRIIM-X clinical trial at EARD 2021.
The TRIIM-X clinical trial aims to understand how to create a personalized thymus regeneration regimen. By regenerating the thymus, the researchers hope to be able to prevent or reverse certain aspects of immune system aging.
FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io
DESCRIPTION
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Dr. Fahy holds a Bachelor of Science degree in Biology from the University of California at Irvine and a Ph.D. from the Medical College of Georgia in Augusta. Dr. Fahy used to be the Head of the Tissue Cryopreservation Section of the Transfusion and Cryopreservation Research Program for the U.S. Naval Medical Research Institute in Bethesda, Maryland, where he developed the original concept of ice blocking agents.
Dr. Fahy is the Chief Scientific Officer and co-founder of Intervene Immune, a biotech company researching rejuvenation of the immune system, particularly the thymus. He designed and led the TRIIM trial, published the first report of thymus regeneration in a normal human, and granted patents on methods for and applications of human thymus regeneration. Before his time at 21st Century Medicine, where he is the Executive Director and Chief Scientific Officer, Dr. Fahy pioneered the practical use of cryopreservation by vitrification and invented a computer system to apply this technology to organs at the American Red Cross.
Dr. Fahy is also a biogerontologist and is the originator and Editor-in-Chief of The Future of Aging: Pathways to Human Life Extension, a multi-authored book about the future of biogerontology.
For 16 years, Dr. Fahy worked as a Director of the American Aging Association and for 6 years as the editor of AGE News, the organization’s newsletter. He currently serves on the editorial boards of Rejuvenation Research and the Open Geriatric Medicine Journal.
The annual Ending Age-Related Diseases (EARD) conference by Lifespan.io brings together longevity thought leaders together to exchange research reports, inspire and get inspired with new ideas, find collaborators, supporters, and mentors.
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero:
lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io
#EARD2021 #Longevity #thymus #thymusregeneration



![Become the CEO of Your Own Health - Kevin Perrott & OpenCures
In this engaging talk, Kevin Perrott, founder of OpenCures, delves into the issue of aging, charting his personal journey from robust health to decline and his subsequent interest in studying this inevitable phenomenon. Perrott critiques the current state of aging research, expressing his frustration over the slow progress despite significant financial investments and increasing societal interest. Perrott introduces an iterative process that seeks to address the issue of aging, fueled by data generated from research. In an attempt to accelerate this process, Perrott suggests creating a collaborative ecosystem of entities and individuals focused on intervention development. He calls for data generation, comprehensive research and insights, and robust intervention strategies, to transform the understanding and treatment of aging.
Perrott also speaks passionately about democratizing healthcare research. He discusses the concept of self-directed researchers and their rights to conduct research on their own health, in alignment with the pursuit of life, liberty, and happiness. He reveals the development of OpenCures, a platform that allows people to access technologies typically reserved for clinical trials and academia. Kevin takes us through the companys journey, from its physical location that provides personal biobanking and other health services, to their development of an open-source platform. He emphasizes the importance of creating a well-functioning ecosystem of related companies.
[00:00:00] Problem: Age-related Loss of Health
[00:02:56] Current Interventions and Their Limitations
[00:04:09] Desperation, Suffering, and the Need for Speed in Solutions
[00:06:05] Intervention Development Cycle, Building a Time Machine
[00:10:44] An Ecosystem for Rapid Intervention
[00:12:21] OpenCures and the right of self-research
[00:14:10] Description of OpenCures physical location and services
[00:15:09] Introduction to OpenCures platform
[00:17:34] LongevityTech.Fund Collaboration and HL.Data
[00:18:47] Strategies to Speed Intervention Development
About the Speaker:
Dr. Kevin Perrott, Ph.D. is Founder and CEO, OpenCures (https://opencures.org/), Adjunct Professor, University of Alberta, Co-Founder and Advisor, Oisin Biotechnologies, President of Global Healthspan Policy Institute, and Co-Founder and Treasurer, SENS Research Foundation.
Kevin is a successful entrepreneur and owner of the largest motorcycle and snowmobile dealership in Canada, Riverside Honda and Skidoo Sales in Edmonton, Alberta. He became a cancer survivor, an experience which clearly highlighted the deficiencies of the current health technology development paradigm where the customer has almost no input in the development of their own health solutions. Armed with the realization that nothing is more valuable than health and the time to enjoy it with those you love, Kevin resolved to put his energies towards addressing these deficiencies.
In 2003, Kevin joined Aubrey de Grey and David Gobel to form the Methuselah Foundation which offered competitive prizes for advances in longevity science. A few years later he became a co-founder with Aubrey de Grey and others of SENS Research Foundation to develop interventions able to repair or make harmless the damage that accumulates and underlies multiple age-related disorders. More recently, Kevin formed OpenCures as a for-benefit corporation helping individuals perform self-directed research, generate data, and focus the value of data on the health solutions they are interested in.
Kevin has authored and co-authored several peer-reviewed articles all focused on accelerating the science underlying the development of therapies for degenerative diseases. He is a co-founder of multiple non-profit and for-profit entities whose missions are aligned with that purpose.
Kevin has a PhD in Biomedical Engineering from University of Alberta, with work performed at the Campisi Lab of the Buck Institute studying the effects of natural compounds on senescence, as well as a BSc, Double Major, in Biology and Chemistry.
FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
https://www.lifespan.io
https://www.facebook.com/lifespanio
https://www.instagram.com/lifespan.io/
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: https://www.lifespan.io/hero
► Subscribe: https://www.youtube.com/user/LifespanIO
► Learn more, and help us: https://www.lifespan.io
#Longevity #Data #Biohacking #OpenCures Become the CEO of Your Own Health - Kevin Perrott & OpenCures](https://i.ytimg.com/vi/goCl_xOx62E/mqdefault.jpg)






